Sfoglia per Autore ALTIERI, MANUELA
Psychometric properties of the Italian version of the Cognitive Reserve Scale (I-CRS)
2018 Altieri, Manuela; Siciliano, Mattia; Pappacena, Simona; Roldán-Tapia, María Dolores; Trojano, Luigi; Santangelo, Gabriella
Regression-based normative data and equivalent scores for Trail Making Test (TMT): an updated Italian normative study
2019 Siciliano, Mattia; Chiorri, Carlo; Battini, Valeria; Sant'Elia, Valeria; Altieri, Manuela; Trojano, Luigi; Santangelo, Gabriella
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study
2019 Santangelo, Gabriella; Altieri, Manuela; Gallo, Antonio; Trojano, Luigi
Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis
2019 Santangelo, Gabriella; Altieri, Manuela; Enzinger, Christian; Gallo, Antonio; Trojano, Luigi
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study
2020 Bisecco, A.; Altieri, M.; Santangelo, G.; Di Nardo, F.; Docimo, R.; Caiazzo, G.; Capuano, R.; Pappacena, S.; D'Ambrosio, A.; Bonavita, S.; Trojsi, F.; Cirillo, M.; Esposito, F.; Tedeschi, G.; Gallo, A.
The Relationships Between Cognitive Reserve and Psychological Symptoms: A Cross-Sectional Study in Healthy Individuals
2020 Altieri, M.; Trojano, L.; Gallo, A.; Santangelo, G.
Functional autonomy in dementia of the Alzheimer’s type, mild cognitive impairment, and healthy aging: a meta-analysis
2021 Altieri, M.; Garramone, F.; Santangelo, G.
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab
2021 Capuano, R.; Donnarumma, G.; Bisecco, A.; Grimaldi, E.; Conte, M.; D'Ambrosio, A.; Matrone, F.; Risi, M.; Borgo, R. M.; Altieri, M.; Giuliano, F.; Coppola, N.; Galdiero, M.; Tedeschi, G.; Gallo, A.
The Psychological Impact of COVID-19 Pandemic and Lockdown on Caregivers of People With Dementia
2021 Altieri, M.; Santangelo, G.
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?
2021 Capuano, R.; Altieri, M.; Bisecco, A.; D'Ambrosio, A.; Docimo, R.; Buonanno, D.; Matrone, F.; Giuliano, F.; Tedeschi, G.; Santangelo, G.; Gallo, A.
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis
2021 Bisecco, A.; Capuano, R.; Caiazzo, G.; D'Ambrosio, A.; Docimo, R.; Cirillo, M.; Russo, A.; Altieri, M.; Bonavita, S.; Rocca, M. A.; Filippi, M.; Tedeschi, G.; Gallo, A.
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis
2022 Altieri, M.; Capuano, R.; Bisecco, A.; D'Ambrosio, A.; Buonanno, D.; Tedeschi, G.; Santangelo, G.; Gallo, A.
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
2022 Altieri, M.; Capuano, R.; Conte, M.; Donnarumma, G.; Grimaldi, E.; Coppola, N.; Galdiero, M.; D'Ambrosio, A.; Tedeschi, G.; Gallo, A.
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod
2022 Capuano, R; Bisecco, A; Conte, M; Donnarumma, G; Altieri, M; Grimaldi, E; Franci, G; Chianese, A; Galdiero, M; Coppola, N; Tedeschi, G; Gallo, A
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
2022 Capuano, Rocco; Altieri, Manuela; Conte, Miriana; Bisecco, Alvino; D'Ambrosio, Alessandro; Donnarumma, Giovanna; Grimaldi, Elena; Coppola, Nicola; Medici, Nicola; Galdiero, Massimiliano; Tedeschi, Gioacchino; Gallo, Antonio
Validation of a short Italian version of the Barratt Impulsiveness Scale (BIS-15) in non-clinical subjects: psychometric properties and normative data
2022 Maggi, G.; Altieri, M.; Ilardi, C. R.; Santangelo, G.
The relationship between depression and cognitive performance in multiple sclerosis: a meta-analysis
2023 Altieri, Manuela; Cerciello, Francesco; Gallo, Antonio; Santangelo, Gabriella
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs
2023 Capuano, R.; Prosperini, L.; Altieri, M.; Lorefice, L.; Fantozzi, R.; Cavalla, P.; Guaschino, C.; Radaelli, M.; Cordioli, C.; Nociti, V.; Boffa, L.; Ragonese, P.; Di Gregorio, M.; Pinardi, F.; Torri Clerici, V.; De Luca, G.; Gajofatto, A.; Paolicelli, D.; Tortorella, C.; Gasperini, C.; Solaro, C.; Cocco, E.; Bisecco, A.; Gallo, A.
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey
2023 Altieri, M.; Capuano, R.; Bisecco, A.; D'Ambrosio, A.; Risi, M.; Cavalla, P.; Vercellino, M.; Annovazzi, P.; Zaffaroni, M.; De Stefano, N.; Stromillo, M. L.; D'Amico, E.; Zanghi, A.; Buscarinu, M. C.; Lanzillo, R.; De Luca, G.; Calabrese, M.; Lorefice, L.; Di Filippo, M.; Valentino, P.; Gajofatto, A.; Marfia, G. A.; Fuiani, A.; Nociti, V.; Tedeschi, G.; Gallo, A.
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence
2023 Altieri, Manuela; Melisi, Rosario Domenico; Conte, Miriana; Capuano, Rocco; Donnarumma, Giovanna; Grimaldi, Elena; Coppola, Nicola; De Pascalis, Stefania; Risi, Mario; D'Ambrosio, Alessandro; Bisecco, Alvino; Gallo, Antonio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Psychometric properties of the Italian version of the Cognitive Reserve Scale (I-CRS) | 1-gen-2018 | Altieri, Manuela; Siciliano, Mattia; Pappacena, Simona; Roldán-Tapia, María Dolores; Trojano, Luigi; Santangelo, Gabriella | |
Regression-based normative data and equivalent scores for Trail Making Test (TMT): an updated Italian normative study | 1-gen-2019 | Siciliano, Mattia; Chiorri, Carlo; Battini, Valeria; Sant'Elia, Valeria; Altieri, Manuela; Trojano, Luigi; Santangelo, Gabriella | |
Does cognitive reserve play any role in multiple sclerosis? A meta-analytic study | 1-gen-2019 | Santangelo, Gabriella; Altieri, Manuela; Gallo, Antonio; Trojano, Luigi | |
Cognitive reserve and neuropsychological performance in multiple sclerosis: A meta-analysis | 1-gen-2019 | Santangelo, Gabriella; Altieri, Manuela; Enzinger, Christian; Gallo, Antonio; Trojano, Luigi | |
Resting-State Functional Correlates of Social Cognition in Multiple Sclerosis: An Explorative Study | 1-gen-2020 | Bisecco, A.; Altieri, M.; Santangelo, G.; Di Nardo, F.; Docimo, R.; Caiazzo, G.; Capuano, R.; Pappacena, S.; D'Ambrosio, A.; Bonavita, S.; Trojsi, F.; Cirillo, M.; Esposito, F.; Tedeschi, G.; Gallo, A. | |
The Relationships Between Cognitive Reserve and Psychological Symptoms: A Cross-Sectional Study in Healthy Individuals | 1-gen-2020 | Altieri, M.; Trojano, L.; Gallo, A.; Santangelo, G. | |
Functional autonomy in dementia of the Alzheimer’s type, mild cognitive impairment, and healthy aging: a meta-analysis | 1-gen-2021 | Altieri, M.; Garramone, F.; Santangelo, G. | |
Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab | 1-gen-2021 | Capuano, R.; Donnarumma, G.; Bisecco, A.; Grimaldi, E.; Conte, M.; D'Ambrosio, A.; Matrone, F.; Risi, M.; Borgo, R. M.; Altieri, M.; Giuliano, F.; Coppola, N.; Galdiero, M.; Tedeschi, G.; Gallo, A. | |
The Psychological Impact of COVID-19 Pandemic and Lockdown on Caregivers of People With Dementia | 1-gen-2021 | Altieri, M.; Santangelo, G. | |
Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience? | 1-gen-2021 | Capuano, R.; Altieri, M.; Bisecco, A.; D'Ambrosio, A.; Docimo, R.; Buonanno, D.; Matrone, F.; Giuliano, F.; Tedeschi, G.; Santangelo, G.; Gallo, A. | |
Regional changes in thalamic shape and volume are related to cognitive performance in multiple sclerosis | 1-gen-2021 | Bisecco, A.; Capuano, R.; Caiazzo, G.; D'Ambrosio, A.; Docimo, R.; Cirillo, M.; Russo, A.; Altieri, M.; Bonavita, S.; Rocca, M. A.; Filippi, M.; Tedeschi, G.; Gallo, A. | |
The psychological impact of Covid-19 pandemic on people with Multiple Sclerosis: A meta-analysis | 1-gen-2022 | Altieri, M.; Capuano, R.; Bisecco, A.; D'Ambrosio, A.; Buonanno, D.; Tedeschi, G.; Santangelo, G.; Gallo, A. | |
Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab | 1-gen-2022 | Altieri, M.; Capuano, R.; Conte, M.; Donnarumma, G.; Grimaldi, E.; Coppola, N.; Galdiero, M.; D'Ambrosio, A.; Tedeschi, G.; Gallo, A. | |
Six-month humoral response to mRNA SARS-CoV-2 vaccination in patients with multiple sclerosis treated with ocrelizumab and fingolimod | 1-gen-2022 | Capuano, R; Bisecco, A; Conte, M; Donnarumma, G; Altieri, M; Grimaldi, E; Franci, G; Chianese, A; Galdiero, M; Coppola, N; Tedeschi, G; Gallo, A | |
Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod | 1-gen-2022 | Capuano, Rocco; Altieri, Manuela; Conte, Miriana; Bisecco, Alvino; D'Ambrosio, Alessandro; Donnarumma, Giovanna; Grimaldi, Elena; Coppola, Nicola; Medici, Nicola; Galdiero, Massimiliano; Tedeschi, Gioacchino; Gallo, Antonio | |
Validation of a short Italian version of the Barratt Impulsiveness Scale (BIS-15) in non-clinical subjects: psychometric properties and normative data | 1-gen-2022 | Maggi, G.; Altieri, M.; Ilardi, C. R.; Santangelo, G. | |
The relationship between depression and cognitive performance in multiple sclerosis: a meta-analysis | 1-gen-2023 | Altieri, Manuela; Cerciello, Francesco; Gallo, Antonio; Santangelo, Gabriella | |
Symptomatic COVID-19 course and outcomes after three mRNA vaccine doses in multiple sclerosis patients treated with high-efficacy DMTs | 1-gen-2023 | Capuano, R.; Prosperini, L.; Altieri, M.; Lorefice, L.; Fantozzi, R.; Cavalla, P.; Guaschino, C.; Radaelli, M.; Cordioli, C.; Nociti, V.; Boffa, L.; Ragonese, P.; Di Gregorio, M.; Pinardi, F.; Torri Clerici, V.; De Luca, G.; Gajofatto, A.; Paolicelli, D.; Tortorella, C.; Gasperini, C.; Solaro, C.; Cocco, E.; Bisecco, A.; Gallo, A. | |
Quality of care provided by Multiple Sclerosis Centers during Covid-19 pandemic: Results of an Italian multicenter patient-centered survey | 1-gen-2023 | Altieri, M.; Capuano, R.; Bisecco, A.; D'Ambrosio, A.; Risi, M.; Cavalla, P.; Vercellino, M.; Annovazzi, P.; Zaffaroni, M.; De Stefano, N.; Stromillo, M. L.; D'Amico, E.; Zanghi, A.; Buscarinu, M. C.; Lanzillo, R.; De Luca, G.; Calabrese, M.; Lorefice, L.; Di Filippo, M.; Valentino, P.; Gajofatto, A.; Marfia, G. A.; Fuiani, A.; Nociti, V.; Tedeschi, G.; Gallo, A. | |
Efficacy and safety of tixagevimab-cilgavimab (Evusheld®) in people with Multiple Sclerosis on Ocrelizumab: preliminary evidence | 1-gen-2023 | Altieri, Manuela; Melisi, Rosario Domenico; Conte, Miriana; Capuano, Rocco; Donnarumma, Giovanna; Grimaldi, Elena; Coppola, Nicola; De Pascalis, Stefania; Risi, Mario; D'Ambrosio, Alessandro; Bisecco, Alvino; Gallo, Antonio |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile